OTX-14-002: Device Exposure Registry

Ocular Therapeutix

Status: Withdrawn

Conditions: Endophthalmitis

Treatments: Device: ReSure Sealant

Study type: Observational

Funder types: Industry

Identifiers

NCT02309736

OTX-14-002

Details and patient eligibility

About

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

All patients that receive at least one application of the ReSure Sealant on the operative eye following cataract surgery will be enrolled.